Skip to main content
Clinical Trials/CTRI/2024/07/070438
CTRI/2024/07/070438
Not yet recruiting
Phase 4

Comparative study of Intramuscular Midazolam, Lorazepam and Haloperidol-Promethazine combination for management of acute agitation. - NI

Government Medical College and Hospital0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Government Medical College and Hospital
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Government Medical College and Hospital

Eligibility Criteria

Inclusion Criteria

  • Altered Mental Status Scale (AMSS) score greater than 1

Exclusion Criteria

  • Patient with known allergy of either midazolam or lorazepam or haloperidol or
  • promethazine.
  • Patient with medically reversible cause of agitation (hypotension, hypoxia or
  • hypoglycemia).
  • Patient known to be pregnant or lactating.
  • Patient presenting with drug withdrawals or drug intoxication within past 48 hours.
  • Patient with history of head injury within past 48 hours.
  • Patient in active Delirium.
  • Patient chemically restrained in past 24 hours.

Outcomes

Primary Outcomes

Not specified

Similar Trials